Ballerup, Denmark and Redwood City, CA, USA – February 1, 2022 – Norlase, an emerging global ophthalmic medical device company, is pleased to announce that Guillermo Molina has joined the company’s Global Sales team as Regional Director, Latin America & Canada. With over fifteen years in international healthcare device sales, most recently at ophthalmic technology manufacturer IRIDEX, Mr. Molina has consistently delivered award-winning sales strategies while supporting the design, development, and launch of numerous products and new technologies.
“Guillermo brings a wealth of experience, expertise, and relationships to our international sales team,” said Greg Fava, Vice President of Medical Devices. “His unparalleled knowledge of the ophthalmic community and its evolving needs in the US, Latin America, and Canada will be invaluable to Norlase’s expansion in these key markets. We look forward to Guillermo’s leadership and vision for educating the market and increasing adoption of Norlase’s next-generation green laser technology among distributors and healthcare professionals.”
A leader in the global salesforce, Mr. Molina has applied his own engineering knowledge to managing medical device portfolios while providing physicians with hands-on applications of medical device equipment. Formerly the Senior Area Sales Manager of The Americas at IRIDEX, he has also provided key market trend analysis and mentored sales team members throughout his career.
“We’re thrilled to have Guillermo join Norlase in our mission to improve access to vision-critical care in LATAM and Canada,” said Oliver Hvidt, Norlase CEO and President. “As we continue to expand and commercialize our world-class products globally, we remain focused on innovation that is truly transformative for ophthalmologists and their patients.”
For more information about Norlase, visit www.norlase.com.
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care and physician convenience for ophthalmologists worldwide. Norlase entered the United States ophthalmic market with LEAF, a new laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit-lamp.
Ballerup, Denmark and Redwood City, CA, USA – February 1, 2022 – Norlase, an emerging global ophthalmic medical device company, is pleased to announce that Guillermo Molina has joined the company’s Global Sales team as Regional Director, Latin America & Canada. With over fifteen years in international healthcare device sales, most recently at ophthalmic technology manufacturer IRIDEX, Mr. Molina has consistently delivered award-winning sales strategies while supporting the design, development, and launch of numerous products and new technologies.
“Guillermo brings a wealth of experience, expertise, and relationships to our international sales team,” said Greg Fava, Vice President of Medical Devices. “His unparalleled knowledge of the ophthalmic community and its evolving needs in the US, Latin America, and Canada will be invaluable to Norlase’s expansion in these key markets. We look forward to Guillermo’s leadership and vision for educating the market and increasing adoption of Norlase’s next-generation green laser technology among distributors and healthcare professionals.”
A leader in the global salesforce, Mr. Molina has applied his own engineering knowledge to managing medical device portfolios while providing physicians with hands-on applications of medical device equipment. Formerly the Senior Area Sales Manager of The Americas at IRIDEX, he has also provided key market trend analysis and mentored sales team members throughout his career.
“We’re thrilled to have Guillermo join Norlase in our mission to improve access to vision-critical care in LATAM and Canada,” said Oliver Hvidt, Norlase CEO and President. “As we continue to expand and commercialize our world-class products globally, we remain focused on innovation that is truly transformative for ophthalmologists and their patients.”
For more information about Norlase, visit www.norlase.com.
About Norlase
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care and physician convenience for ophthalmologists worldwide. Norlase entered the United States ophthalmic market with LEAF, a new laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit-lamp.
DIDN’T FIND WHAT YOU’RE LOOKING FOR?
Let us know how we can help!
DIDN’T FIND WHAT YOU
WERE LOOKING FOR?
Let us know how we can help!
